*ST生物：11月28日召开董事会会议

Group 1 - The core point of the article is that *ST Bio (SZ 000504) held its 12th sixth board meeting on November 28, 2025, via telecommunication to discuss the appointment of the auditing firm for the year 2025 [1] - For the first half of 2025, *ST Bio's revenue composition is as follows: stem cell industry accounts for 83.88%, energy-saving technology services account for 15.87%, and other businesses account for 0.25% [1] - As of the report, *ST Bio has a market capitalization of 3.1 billion yuan [1]